IFNA1 and Dravet syndrome: The fact that gene signatures of IFN hyperactivity are present in human embryonic tissues with T2159 and embryonic tissues from mouse models of DS50,60 indicates that the harmful effects of IFN hyperactivity could start in utero, supporting the notion that DS could be understood, in part, as an inborn error of immunity with similarities to monogenic interferonopathies61.